Survival and determinants of all-cause mortality during treatment among patients with pulmonary and extrapulmonary tuberculosis in Sakon Nakhon Province, Northeastern Thailand: a ten-year retrospective cohort study

Abstract Background In 2023, there were an estimated 10.8 million new cases of tuberculosis (TB) globally and 1.25 million TB-related deaths; TB remains one of the leading causes of death from a single infectious agent worldwide. Despite considerable improvements in TB control, long-term survival patterns among TB patients in rural community settings, particularly in northeastern Thailand, remain poorly characterized. Methods A retrospective cohort study was conducted using data (fiscal years 2014–2023) on 9,289 pulmonary and extrapulmonary TB patients registered in Sakon Nakhon Province, Thailand. Data were retrieved from the National TB Information System (NTIP) and refined to an evaluable cohort ( n = 8,895) for time-to-event analyses, after excluding patients who transferred out ( n = 95) or whose diagnosis was changed ( n = 299). Analyses used Kaplan-Meier survival estimation, the log-rank test, and multivariable Cox proportional hazards regression, with statistical significance set at p < 0.05. Results Among the 9,289 registered TB patients (mean age 52.6 ± 16.7 years), 63.6% were male (male-to-female ratio 1.74:1), 21.6% had HIV co-infection, and 0.4% had documented multidrug- or rifampicin-resistant TB (MDR/RR-TB). The overall treatment success rate was 85.6% (46.8% cured and 38.8% treatment completed). All-cause case fatality during treatment (i.e., death from any cause, not specifically attributed to TB) was 7.4% overall, with 3.8% of patients dying within the first 2 months of treatment (early mortality). Median survival time among patients who died was approximately 6.0 months (mean 6.6 ± 3.0 months). Case fatality rose continuously from 3.5% in 2014 to 9.1% in 2023 (χ² test for trend, p < 0.001), while the treatment success rate declined from 92.1% to 82.6% over the same period. In multivariable Cox regression, all-cause mortality during treatment was independently associated with age ≥ 65 years (adjusted hazard ratio [aHR] 2.67, 95% CI 2.18–3.28, p < 0.001) and HIV co-infection (aHR 1.55, 95% CI 1.30–1.84, p < 0.001). Conclusions Median survival among patients who died was approximately 6.0 months. Advanced age (≥ 65 years) and HIV co-infection were the strongest independent predictors of all-cause mortality, and case fatality rose steadily over the ten-year study period. These findings point to older, HIV-co-infected, and geographically disadvantaged patients as priority groups for integrated, targeted TB care in this rural Thai setting. All reported mortality and case-fatality figures reflect all-cause deaths during TB treatment, not TB-specific mortality, since cause of death was not reliably recorded in the registry.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2026-11-16
DOI
https://doi.org/10.1186/s12879-026-14805-2
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Survival and determinants of all-cause mortality during treatment among patients with pulmonary and extrapulmonary tuberculosis in Sakon Nakhon Province, Northeastern Thailand: a ten-year retrospective cohort study

Warinmad Kedthongma, Nitikorn Phoosuwan, Wuttiphong Phakdeekul, Somrak Sirikhetkon et al.
BMC Infectious Diseases
Tuberculosis Research and Epidemiology
article

Survival and determinants of all-cause mortality during treatment among patients with pulmonary and extrapulmonary tuberculosis in Sakon Nakhon Province, Northeastern Thailand: a ten-year retrospective cohort study

Warinmad Kedthongma, Nitikorn Phoosuwan, Wuttiphong Phakdeekul, Somrak Sirikhetkon, Sopon Usaprom
article en

Abstract

Abstract Background In 2023, there were an estimated 10.8 million new cases of tuberculosis (TB) globally and 1.25 million TB-related deaths; TB remains one of the leading causes of death from a single infectious agent worldwide. Despite considerable improvements in TB control, long-term survival patterns among TB patients in rural community settings, particularly in northeastern Thailand, remain poorly characterized. Methods A retrospective cohort study was conducted using data (fiscal years 2014–2023) on 9,289 pulmonary and extrapulmonary TB patients registered in Sakon Nakhon Province, Thailand. Data were retrieved from the National TB Information System (NTIP) and refined to an evaluable cohort ( n = 8,895) for time-to-event analyses, after excluding patients who transferred out ( n = 95) or whose diagnosis was changed ( n = 299). Analyses used Kaplan-Meier survival estimation, the log-rank test, and multivariable Cox proportional hazards regression, with statistical significance set at p < 0.05. Results Among the 9,289 registered TB patients (mean age 52.6 ± 16.7 years), 63.6% were male (male-to-female ratio 1.74:1), 21.6% had HIV co-infection, and 0.4% had documented multidrug- or rifampicin-resistant TB (MDR/RR-TB). The overall treatment success rate was 85.6% (46.8% cured and 38.8% treatment completed). All-cause case fatality during treatment (i.e., death from any cause, not specifically attributed to TB) was 7.4% overall, with 3.8% of patients dying within the first 2 months of treatment (early mortality). Median survival time among patients who died was approximately 6.0 months (mean 6.6 ± 3.0 months). Case fatality rose continuously from 3.5% in 2014 to 9.1% in 2023 (χ² test for trend, p < 0.001), while the treatment success rate declined from 92.1% to 82.6% over the same period. In multivariable Cox regression, all-cause mortality during treatment was independently associated with age ≥ 65 years (adjusted hazard ratio [aHR] 2.67, 95% CI 2.18–3.28, p < 0.001) and HIV co-infection (aHR 1.55, 95% CI 1.30–1.84, p < 0.001). Conclusions Median survival among patients who died was approximately 6.0 months. Advanced age (≥ 65 years) and HIV co-infection were the strongest independent predictors of all-cause mortality, and case fatality rose steadily over the ten-year study period. These findings point to older, HIV-co-infected, and geographically disadvantaged patients as priority groups for integrated, targeted TB care in this rural Thai setting. All reported mortality and case-fatality figures reflect all-cause deaths during TB treatment, not TB-specific mortality, since cause of death was not reliably recorded in the registry.

BMC Infectious Diseases
Thammasat University (TH), Uppsala University (SE), Ministry of Public Health (TH), Kasetsart University (TH), Department of Disease Control (TH)
Kasetsart University
Good health and well-being
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon